Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.780
-0.080 (-4.30%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $148.65 million as of September 17, 2025. Its market cap has increased by 17.78% in one year.
Market Cap
148.65M
Enterprise Value
152.45M
1-Year Change
17.78%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $148.65M, an increase of 64.78%. That is a compound annual growth rate of 19.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 155.34M | 88.78% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |